Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 425,934 | N/A | 434,000 | 437,814 | 494,673 |
| Income taxes - deferred | -32,633 | N/A | N/A | -22,373 | 18,609 |
| Accounts receivable | -75,809 | -85,000 | 326,000 | -356,848 | -3,760 |
| Accounts payable and accrued liabilities | -26,646 | N/A | N/A | 36,125 | -113,043 |
| Other Working Capital | 122,243 | N/A | 378,000 | -337,674 | 56,106 |
| Other Operating Activity | 305,977 | 845,000 | -131,000 | 385,791 | 147,074 |
| Operating Cash Flow | $719,066 | $760,000 | $1,007,000 | $142,835 | $599,659 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -238,868 | N/A | -155,000 | -140,493 | -201,984 |
| Net Acquisitions | 132,518 | N/A | N/A | 8,072 | -15,530 |
| Purchase Of Investment | -4,226 | N/A | N/A | -45,886 | -13,510 |
| Sale Of Investment | 14,075 | N/A | N/A | 15,030 | 6,079 |
| Other Investing Activity | 0 | 0 | -155,000 | 0 | 0 |
| Investing Cash Flow | $-96,501 | $N/A | $-310,000 | $-163,277 | $-224,945 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -133,712 | N/A | N/A | 44,966 | 99,626 |
| Debt Issued | 207,310 | N/A | N/A | 6,472 | -63,263 |
| Debt Repayment | -753,634 | N/A | N/A | -200,276 | -184,779 |
| Other Financing Activity | -65,618 | 0 | 0 | 150,852 | 28,500 |
| Financing Cash Flow | $-745,654 | $N/A | $N/A | $2,014 | $-119,916 |
| Exchange Rate Effect | -24,045 | N/A | N/A | -31,469 | -94,563 |
| Beginning Cash Position | 1,574,359 | N/A | N/A | 1,273,787 | 1,113,552 |
| End Cash Position | 1,427,225 | N/A | N/A | 1,223,890 | 1,273,787 |
| Net Cash Flow | $-123,089 | $N/A | $N/A | $-18,428 | $254,798 |
| Free Cash Flow | |||||
| Operating Cash Flow | 719,066 | 760,000 | 1,007,000 | 142,835 | 599,659 |
| Capital Expenditure | -250,278 | -271,000 | -310,000 | -142,131 | -229,384 |
| Free Cash Flow | 468,788 | 489,000 | 697,000 | 704 | 370,275 |